ICGex + Curie BioinfoManuel Rodrigues et al. Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial Nature Communications 2023, vol. 14, issue 1 doi: 10.1038/s41467-023-39383-8 2023Sélection 2023 Phages against Noncapsulated Klebsiella pneumoniae: Broader Host range, Slower ResistanceToutes les publicationsDeSUMOylation of chromatin-bound proteins limits the rapid transcriptional reprogramming induced by daunorubicin in acute myeloid leukemias
